Predict your next investment

HEALTHCARE | Biotechnology
ocerainc.com

See what CB Insights has to offer

Founded Year

2005

Stage

Acq - P2P | Acquired

Total Raised

$62M

Valuation

$0000 

About Ocera Therapeutics

Ocera Therapeutics is focused on the development and commercialization of therapeutics for gastrointestinal and liver diseases. The company's portfolio consists of OCR-002 and AST-120. OCR-002 is an ammonia scavenger in development for the treatment and prevention of hyperammonemia and resultant Acute Hepatic Encephalopathy (AHE) in patients with liver cirrhosis and Acute Liver Failure (ALF). OCR-002 is developed in both oral and IV formulations. AST-120 is a microspherical carbon adsorbent with selective adsorption profile for a variety of unwanted substances in the digestive tract. These substances may be responsible for a number of conditions, including Hepatic Encephalopathy (HE), Irritable Bowel Syndrome (IBS), and pouchitis. They include ammonia, indoles (serotonin, octopamine), histamine, secondary bile acids, advanced glycation endproducts (AGE), and certain bacterial toxins.

Ocera Therapeutics Headquarter Location

555 Twin Dolphin Drive Suite 615

Redwood City, California, 94065,

United States

650-475-0158

Latest Ocera Therapeutics News

Ocera Therapeutics Inc Mergers Acquisitions MA Partnerships Alliances and Investment Report Report Updated 28072018 Prices from USD $350

Nov 6, 2018

Printed From BioPortfolio.com Ocera Therapeutics Inc Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Report Updated: 28072018] Prices from USD $350 18:46 EST 5 Nov 2018 | BioPortfolio Reports Ocera Therapeutics Inc Mergers Acquisitions MA, Partnerships Alliances and Investment Report Summary Marketline's Ocera Therapeutics Inc Mergers Acquisitions MA, Partnerships Alliances and Investments report includes business description, detailed reports on mergers and acquisitions MA, divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Ocera Therapeutics Inc since January2007. Synopsis Marketline's Company Mergers Acquisitions MA, Partnerships Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Key Highlights This report includes Ocera Therapeutics Inc's contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed. The profile also includes detailed deal reports for all MA, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Ocera Therapeutics Inc. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed. Scope Provides intelligence on Ocera Therapeutics Inc's MA, strategic partnerships and alliances, capital raising and private equity transactions. Detailed reports of various financial transactions undertaken by Ocera Therapeutics Inc and its subsidiaries since 2007. Information about key financial and legal advisors for Ocera Therapeutics Inc's financial deals transactions. Financial deals tables and charts covering deal value and volumes trend, deal types and geographybased deal activity. Reasons to buy Access comprehensive financial deals data along with charts and graph covering MA, private equity, and partnerships and alliances. Form an independent opinion about Ocera Therapeutics Inc's growth strategies through the organic and inorganic activities undertaken since 2007. Track your competitors' business structure and growth strategies. Related Biotechnology, Pharmaceutical and Healthcare News

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Ocera Therapeutics

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Ocera Therapeutics is included in 1 Expert Collection, including Biopharmaceuticals.

B

Biopharmaceuticals

14,140 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

Ocera Therapeutics Patents

Ocera Therapeutics has filed 26 patents.

The 3 most popular patent topics include:

  • Rare diseases
  • Hepatology
  • Diseases of liver
patents chart

Application Date

Grant Date

Title

Related Topics

Status

1/31/2020

11/2/2021

Monoclinic minerals, Acetate esters, Hepatology, Diseases of liver, Rare diseases

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

1/31/2020

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

11/2/2021

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Monoclinic minerals, Acetate esters, Hepatology, Diseases of liver, Rare diseases

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.